Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis

Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis

ObjectiveThis study aimed to compare the efficacy of novel oral anticoagulants (NOACs) with traditional anticoagulants vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) post transcatheter aortic valve replacement (TAVR).MethodsStudies comparing the usage of NOACs and VKAs in AF...

Full description

Bibliographic Details
Main Authors:	Lu Wang, Wanyue Sang, Yi Jian, Xiaoxue Zhang, Yafan Han, Feifei Wang, Liang Wang, Suxia Yang, Subinuer Wubulikasimu, Li Yang, Huaxin Sun, Yaodong Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	transcatheter aortic valve replacement atrial fibrillation anticoagulant therapy new oral anticoagulants vitamin K antagonists
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1175215/full

Similar Items

Feasibility study of cryoballoon ablation for atrial fibrillation with KODEX-EPD: a single center experience
by: Subinuer Wubulikasimu, et al.
Published: (2023-12-01)

Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study
by: Yafan Han, et al.
Published: (2024-03-01)

Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention
by: Enrico Guido Spinoni, et al.
Published: (2022-02-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve
by: Yalin Cao, et al.
Published: (2022-06-01)

Feasibility, safety and effectiveness of mapping system assisted conduction system pacing: a single-center prospective study
by: Liang Wang, et al.
Published: (2023-06-01)

Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRY
by: Christina Köhler, et al.
Published: (2023-07-01)

Warfarin involvement, in comparison to NOACs, in the development of systemic atherosclerosis
by: Romeo Gabriel Mihaila
Published: (2022-05-01)

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
by: Jan Beyer-Westendorf, et al.
Published: (2021-04-01)

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
by: Stephanie Müller, et al.
Published: (2022-10-01)

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
by: Angela Saviano, et al.
Published: (2022-11-01)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
by: Tomas L. Lindahl, et al.
Published: (2017-07-01)

Novel Oral Anti Coagulants (NOACs) as Anti Thrombotic on Atrial Fibrillation Patients
by: Abed Nego Okthara Sebayang
Published: (2020-02-01)

Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
by: Lorenzo Pradelli, et al.
Published: (2014-12-01)

Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
by: Lorenzo Pradelli, et al.
Published: (2014-12-01)

Improved stacking ensemble learning based on feature selection to accurately predict warfarin dose
by: Mingyuan Wang, et al.
Published: (2024-01-01)

Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies
by: Fuwei Liu, et al.
Published: (2021-11-01)

Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
by: Jovanović Dejana R.
Published: (2020-01-01)

Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery
by: Mattia Manfredini, et al.
Published: (2021-11-01)

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
by: Hyeongsoo Kim, et al.
Published: (2020-01-01)

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study
by: Maurizio Paciaroni, et al.
Published: (2017-12-01)

Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis
by: Jing Wen Yong, et al.
Published: (2017-12-01)

In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment
by: Feifei Wang, et al.
Published: (2022-08-01)

TAVR, NOACs, NAFLD, and a Happy New Year
by: Çetin Erol
Published: (2019-12-01)

Dislodged Watchman Device Retrieved Using Double Transseptal Sheaths Technique and Reinstalled with LAmbre Device
by: yafan han, et al.
Published: (2022-05-01)

Full-Length Transcriptome Sequencing: An Insight Into the Dog Model of Heart Failure
by: Xiaoyan Liang, et al.
Published: (2021-12-01)

Evaluation of drug adherence in patients with non-valvular atrial fibrillation according to geographic regions of Turkey: an analysis from NOAC-TR study
by: Volkan Emren, et al.
Published: (2017-12-01)

Perioperative management of ophthalmic patients on antithrombotic therapy
by: Jin Yan, et al.
Published: (2015-07-01)

Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury
by: De-Lin Liu, et al.
Published: (2016-01-01)

Should We Continue Assessing Glomerular Filtration Rate with the Cockroft–Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem
by: Roberto Cemin, et al.
Published: (2020-06-01)

Research progress of antithrombotic drugs
by: ZHANG Jie, MA Xuzhou, LI Huihui, WANG Miao
Published: (2023-01-01)

Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review
by: Hongjie Li, et al.
Published: (2020-12-01)

Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis
by: Ghanshyam Patel, et al.
Published: (2023-09-01)

Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis
by: Fuwei Liu, et al.
Published: (2022-06-01)

The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis
by: Cornelia Ghea, et al.
Published: (2023-01-01)

The use of apixaban as a perioperative bridge for warfarin in a patient unable to use parenteral anticoagulation: A case report
by: Eric A. Dietrich, et al.
Published: (2021-08-01)

A Deep Overview of Anticoagulant Drugs: Recent Synthesis and Their Activity Assay
by: Engrid Juni Astuti, et al.
Published: (2024-04-01)

Beyond warfarin: The advent of new oral anticoagulants
by: Sandeep T Laroia, et al.
Published: (2015-10-01)

Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
by: Chi-Juei Jeng, et al.
Published: (2022-03-01)

Clinical study of anticoagulant therapy in patients with severe coronavirus disease: A single-center retrospective analysis
by: Peng Zhou, et al.
Published: (2021-01-01)